CD244-/- mice showed impaired tumor growth of HNSCC, and anti-SLAMF4 treatment also impaired the growth of established HNSCC tumors while it increased CD8+ TIL infiltration, suggesting SLAMF4 plays an inhibitory role in the immune response to HNSCC (62). Here, CD244 is linked to head and neck squamous cell carcinoma.